9 held for selling drugs meant for defence, ESIC hospitals

Image
Press Trust of India Thane
Last Updated : May 21 2019 | 12:56 PM IST

The Navi Mumbai police in Maharashtra claimed to have busted an inter-state racket of illegal sale of medicines meant for defence and ESIC hospitals and arrested nine people, an official said on Tuesday.

The accused allegedly procured an anti-diabetic medicine, Galvus 50 mg manufactured by Novartis company, for sale in the retail market by erasing its stamp mentioning 'for defence' and 'not for sale', Navi Mumbai Police Commissioner Sanjay Kumar said in a release.

The drug stock was exclusively meant for supply in defence and Employees' State Insurance Corporation (ESIC)-run hospitals, the police said.

The investigation revealed that the medicine was procured from Pune, Mumbai and Navi Mumbai in Maharashtra and from other others place like Amritsar (Punjab), Jammu, Delhi, Agra, Lucknow (Uttar Pradesh), Indore (Madhya Pradesh) and Patna (Bihar), he said.

After erasing the declaration of 'defence supply' and 'not for sale' from the drug strips with special chemicals, they were allegedly sold with fake bills to the Medlife online pharmacy company, he said.

The police got a tip-off after the Food and Drug Administration (FDA) officials recently found the drug stock lying at the online pharmacy's unit in Taloja area of the neighbouring Raigad district, he said.

Those arrested were identified as Mahesh Nagansure (36), Sachin Vadaskar (29), Sachin Baldava (42), all from a drug distribution unit in Navi Mumbai, Nirajkumar Singh (26) from a pharmacy in Pune, Sanjay Garg (49) and Tarun Madan (30) from Delhi, Harprasad Gupta (47) and Shivam Gupta (26) from Agra and Dinesh Mahajan (30) from Jammu.

They were booked under Indian Penal Code sections for cheating and forgery, and provisions of the Drugs and Cosmetics Act, the police said.

A probe was on and some more arrests were likely in the case, Deputy Commissioner of Police (Crime) Tushar Doshi said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 21 2019 | 12:56 PM IST

Next Story